- Highest-ever annual ADV of 5.5 million contracts also
reached in 2023
CHICAGO, Nov. 28,
2023 /PRNewswire/ -- CME Group, the world's leading
derivatives marketplace, today announced that open interest in its
deeply liquid U.S. Treasury futures set a new record
of 21,428,757 contracts on November
24.
This year, the notional value of open interest in CME Group U.S.
Treasury futures grew to $2.57
trillion, an increase of 50% year-over-year, as the average
daily volume (ADV) reached 5.5 million contracts, the highest
annual level ever.
"Throughout 2023, we have seen record volume and open interest
in our U.S. Treasury futures, which offer market participants the
most efficient and liquid products to hedge risk across the yield
curve," said Agha Mirza, CME Group
Global Head of Rates and OTC Products. "We are particularly pleased
with the breadth of our market's liquidity profile and overall
participation, as measured by large open interest holders in the
CFTC's commitment of traders report. Amid our third consecutive
year of record ADV, this indicates the market will remain deeply
liquid, while it continues to enable record risk transfer."
CME Group delivers the market's leading electronic, central
limit order book for every tenor of U.S. Treasury futures, which
trade side-by-side on the CME Globex platform with BrokerTec cash
securities. In addition, clients benefit from the flexibility of
privately negotiated transactions in the form of blocks, exchange
for risk (EFR) and exchange of futures for physical (EFP)
agreements. Clients using these tools to manage risk include
sovereigns, banks, asset managers, hedge funds, principal trading
firms and other institutions.
U.S. Treasury futures receive margin offsets against existing
CME Group Interest Rate products, and are listed with, and subject
to, the rules of CBOT. These contracts are also eligible for
portfolio margining against other cleared interest rate swaps and
futures.
For more information on CME Group U.S. Treasury futures, please
visit our product page here.
About CME Group
As the world's leading derivatives marketplace, CME Group
(www.cmegroup.com) enables clients to trade futures, options, cash
and OTC markets, optimize portfolios, and analyze data – empowering
market participants worldwide to efficiently manage risk and
capture opportunities. CME Group exchanges offer the widest range
of global benchmark products across all major asset classes based
on interest rates, equity indexes, foreign
exchange, energy, agricultural
products and metals. The company offers futures and
options on futures trading through the CME Globex platform,
fixed income trading via BrokerTec and foreign exchange trading on
the EBS platform. In addition, it operates one of the world's
leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange,
Globex, and, E-mini are trademarks of Chicago Mercantile Exchange
Inc. CBOT and Chicago Board
of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York
Mercantile Exchange and ClearPort are trademarks of New York
Mercantile Exchange, Inc. COMEX is a trademark of Commodity
Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe
LTD and EBS Group LTD, respectively. The S&P 500 Index is a
product of S&P Dow Jones Indices LLC ("S&P DJI").
"S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are
trademarks of Standard & Poor's Financial Services LLC; Dow
Jones®, DJIA® and Dow Jones Industrial Average are service and/or
trademarks of Dow Jones Trademark Holdings LLC. These trademarks
have been licensed for use by Chicago Mercantile Exchange Inc.
Futures contracts based on the S&P 500 Index are not sponsored,
endorsed, marketed, or promoted by S&P DJI, and S&P DJI
makes no representation regarding the advisability of investing in
such products. All other trademarks are the property of their
respective owners.
CME-G
View original
content:https://www.prnewswire.com/news-releases/cme-group-us-treasury-futures-open-interest-surpasses-record-21-million-contracts-301998630.html
SOURCE CME Group